FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENTSecurities Purchase Agreement and Registration Rights Agreement • August 14th, 2023 • Allarity Therapeutics, Inc. • Pharmaceutical preparations
This Frist Amendment to Securities Purchase Agreement and Registration Rights Agreement (the “Agreement”) is entered into this 8th day of October, 2021, by and between Allarity Therapeutics, Inc., a Delaware corporation with offices located at 210 Broadway, Ste 201, Cambridge, MA 02139 (the “Company”), Allarity Therapeutics A/S, a Danish public limited company located at Venlighedsvej 1, 2970 Horsholm, Denmark (the “Parent”) and 3i, LP, a Delaware limited partnership with offices located at 140 Broadway, 38th Floor New York, NY 10005 (the “Buyer” and collectively with the Company and the Parent, the “Parties” and each a “Party”).
